Jounce Therapeutics Inc
(JNCE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Sales | 82,000 | 26,907 | 62,339 | 147,872 | 65,201 |
| Gross Profit | 82,000 | 26,907 | 62,339 | 147,872 | 65,201 |
| Operating Expenses | 134,242 | 117,963 | 107,456 | 95,055 | 96,495 |
| Operating Income | -52,242 | -91,056 | -45,117 | 52,817 | -31,294 |
| Other Income | 1,458 | 199 | 1,289 | 4,052 | 3,961 |
| Pre-tax Income | -50,784 | -90,857 | -43,828 | 56,869 | -27,333 |
| Income Tax | 135 | 15 | 14 | 46 | 46 |
| Net Income Continuous | -50,919 | -90,872 | -43,842 | 56,823 | -27,379 |
| Net Income | $-50,919 | $-90,872 | $-43,842 | $56,823 | $-27,379 |
| EPS Basic Total Ops | -0.99 | -1.82 | -1.24 | 1.72 | -0.84 |
| EPS Basic Continuous Ops | -0.99 | -1.82 | -1.24 | 1.72 | -0.84 |
| EPS Diluted Total Ops | -0.99 | -1.82 | -1.24 | 1.66 | -0.84 |
| EPS Diluted Continuous Ops | -0.99 | -1.82 | -1.24 | 1.66 | -0.84 |
| EPS Diluted Before Non-Recurring Items | N/A | -1.82 | -1.24 | 1.66 | -0.84 |
| EBITDA(a) | $-49,252 | $-87,308 | $-41,669 | $55,188 | $-28,570 |